News

NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne.  Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...

A unique technology for the construction industry offering immersive “walk throughs” of unbuilt houses; a novel method of recycling print toner powder for use across a range of applications including art, construction and animal medicines; and a technique for new drug discovery are among the...

Locate Therapeutics, a leading UK regenerative medicine company has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration.Locate Therapeutics are a biomaterials-focussed company that...

Leading UK-based DMPK provider has taken tenancy at BioHub, Alderley Park, increasing its foothold in the UK. XenoGesis which was founded in 2011 by Dr Richard Weaver, has seen continued growth at its headquarters at BioCity Nottingham. Now employing 25 members of staff, the business has...

NuVision Biotherapies, based at BioCity Nottingham, is a regenerative medicine company who have developed a groundbreaking therapy that can help prevent sight loss. This week they have completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham.The investment...